Génomic Vision SA SMA 50
¿Qué es el SMA 50 de Génomic Vision SA?
El SMA 50 de Génomic Vision SA es €0 +100.00%
¿Cuál es la definición de SMA 50?
SMA 50 es un precio promedio de las acciones de los últimos 50 días calculado como una media no ponderada de los previos 50 precios de cierre de acciones.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 de compañías en Sector Health Care en EURONEXT en comparadas con Génomic Vision SA
¿Qué hace Génomic Vision SA?
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
Empresas con sma 50 similar a Génomic Vision SA
- Génomic Vision SA tiene SMA 50 de €0 +100.00%
- EVmo Inc tiene SMA 50 de $0 +99.75%
- Blue Capital Reinsurance Ltd tiene SMA 50 de $0 -Inf%
- Kaleido Biosciences Inc tiene SMA 50 de $0 +59.40%
- Yangtze River Port and Logistics Ltd tiene SMA 50 de $0 +28.25%
- iFresh Inc tiene SMA 50 de $0 +0.00%
- Aridis Pharmaceuticals Inc tiene SMA 50 de $0 +83.25%